WuXi Biologics

WuXi Biologics Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

WuXi Biologics key operating metrics including Pre-clinical Projects, environmental, and social and governance score (ESG).

Pre-clinical Projects

287

35.4%

H1, 2022

Late-phase Projects

34.4%

H1, 2022

Phase I Projects

144

24.1%

H1, 2022

Operating Metrics

Metrics	FY, 2019	FY, 2020	FY, 2021
Pre-clinical Projects	121	169	268
Late-phase Projects	16	28	32
Phase I Projects	85	103	119
Phase II Projects	27	32	52
Commercial Manufacturing Projects	1	2	7
Backlog	$5.1B	$11.3B	$13.6B
New Projects	59
Service Backlog	$1.7B	$6.6B	$7.9B
Backlog (Upcoming Potential Milestone Fees)	$3.4B	$4.7B	$5.7B
Integrated Projects	250	334	480
Early-phase Projects	112	135	171

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub